Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Haase, Kerstin"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity.
Autorzy:
Watkins TBK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.
Colliver EC; The Francis Crick Institute, London, United Kingdom.
Huska MR; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin, Germany.
Kaufmann TL; BIFOLD-Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.; Department of Electrical Engineering & Computer Science, Technische Universität Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin, Germany.; Institute for Computational Cancer Biology (ICCB), Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Lim EL; The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.
Duncan CB; Institute for Computational Cancer Biology (ICCB), Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Haase K; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Van Loo P; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Swanton C; The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Medical Oncology, University College London Hospitals, London, United Kingdom.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom.
Schwarz RF; Institute for Computational Cancer Biology (ICCB), Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; BIFOLD-Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin, Germany.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Oct 23; Vol. 19 (10), pp. e1011379. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
DNA Copy Number Variations*/genetics
Neoplasms*/genetics
Neoplasms*/pathology
Humans ; Haplotypes/genetics ; Algorithms
Czasopismo naukowe
Tytuł:
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
Autorzy:
Camacho N; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom.; Department of Human Genetics, University of Leuven, Leuven, Belgium.
Edwards S; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
Kay JD; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom.
Matthews L; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom.
Clark J; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Dennis N; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Thomas S; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Kremeyer B; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Zamora J; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Gundem G; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Merson S; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
Luxton H; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom.
Hawkins S; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
Ghori M; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Marsden L; Department of Physiology, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Lambert A; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom.
Karaszi K; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Pelvender G; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Massie CE; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; CRUK Cambridge Centre, Early Detection Programme, Urological Malignancies Programme, Hutchison-MRC Research Centre, Cambridge, Cambridgeshire, United Kingdom.
Kote-Jarai Z; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.
Raine K; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Howat WJ; Histopathology and in situ hybridization Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.
Hazell S; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Livni N; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Fisher C; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Ogden C; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Kumar P; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Thompson A; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Nicol D; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Mayer E; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Dudderidge T; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Yu Y; Department of Epidemiology, Second Military Medical University, Shanghai, China.
Zhang H; Department of Epidemiology, Second Military Medical University, Shanghai, China.
Shah NC; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
Isaacs W; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Visakorpi T; Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere and Tampere University Hospital, Tampere, Finland.
Hamdy F; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Berney D; Centre for Molecular Oncology, Barts Cancer Institute, The Barts and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Verrill C; Department of Cellular Pathology and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom.
Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom.
Wedge DC; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Oxford Big Data Institute & Oxford Centre for Cancer Gene Research, Wellcome Trust Centre for Human Genetics, Oxford, Oxfordshire, United Kingdom.
Lynch AG; Statistics and Computational Biology Laboratory, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; School of Mathematics and Statistics/School of Medicine, University of St Andrews, St Andrews, Fife, Scotland.
Foster CS; HCA Pathology Laboratories, HCA Healthcare, London, United Kingdom.
Lu YJ; Centre for Molecular Oncology, Barts Cancer Institute, The Barts and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Bova GS; Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere and Tampere University Hospital, Tampere, Finland.
Whitaker HC; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom.
McDermott U; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Neal DE; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
Eeles R; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Cooper CS; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Brewer DS; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.; Organisms and Ecosystems, The Earlham Institute, Norwich, Norfolk, United Kingdom.
Pokaż więcej
Corporate Authors:
CRUK-ICGC Prostate Group
Źródło:
PLoS genetics [PLoS Genet] 2017 Sep 25; Vol. 13 (9), pp. e1007001. Date of Electronic Publication: 2017 Sep 25 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Sequence Analysis, DNA*
DNA Copy Number Variations/*genetics
Prostatic Neoplasms/*genetics
RNA, Long Noncoding/*genetics
Alleles ; Genome, Human ; Genomics ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Prostatectomy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Sequence Deletion
Czasopismo naukowe
Tytuł:
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Autorzy:
Dentro, Stefan C. (AUTHOR)
Leshchiner, Ignaty (AUTHOR)
Haase, Kerstin (AUTHOR)
Tarabichi, Maxime (AUTHOR)
Wintersinger, Jeff (AUTHOR)
Deshwar, Amit G. (AUTHOR)
Yu, Kaixian (AUTHOR)
Rubanova, Yulia (AUTHOR)
Macintyre, Geoff (AUTHOR)
Demeulemeester, Jonas (AUTHOR)
Vázquez-García, Ignacio (AUTHOR)
Kleinheinz, Kortine (AUTHOR)
Livitz, Dimitri G. (AUTHOR)
Malikic, Salem (AUTHOR)
Donmez, Nilgun (AUTHOR)
Sengupta, Subhajit (AUTHOR)
Anur, Pavana (AUTHOR)
Jolly, Clemency (AUTHOR)
Cmero, Marek (AUTHOR)
Rosebrock, Daniel (AUTHOR)
Pokaż więcej
Źródło:
Cell. Apr2021, Vol. 184 Issue 8, p2239-2239. 1p.
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies